BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1300481)

  • 1. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced astrogliosis does not require activation of ornithine decarboxylase.
    O'Callaghan JP; Seidler FJ
    Neurosci Lett; 1992 Dec; 148(1-2):105-8. PubMed ID: 1300481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Difluoromethylornithine counteracts lesion-induced astrogliosis in rat hippocampus: enhancement of inhibitory effect by combined treatment with GM1 ganglioside.
    Jegliński W; Skup M; Zaremba M; Oderfeld-Nowak B
    Acta Neurobiol Exp (Wars); 1996; 56(2):549-53. PubMed ID: 8768305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced damage of striatal dopaminergic fibers attenuates subsequent astrocyte response to MPTP.
    O'Callaghan JP; Miller DB; Reinhard JF
    Neurosci Lett; 1990 Sep; 117(1-2):228-33. PubMed ID: 1981254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a role of neosynthetized putrescine in the increase of glial fibrillary acidic protein immunoreactivity induced by a mechanical lesion in the rat brain.
    Zini I; Zoli M; Grimaldi R; Pich EM; Biagini G; Fuxe K; Agnati LF
    Neurosci Lett; 1990 Nov; 120(1):13-6. PubMed ID: 2293084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neurotoxicant MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) increases glial fibrillary acidic protein and decreases dopamine levels of the mouse striatum: evidence for glial response to injury.
    Reinhard JF; Miller DB; O'Callaghan JP
    Neurosci Lett; 1988 Dec; 95(1-3):246-51. PubMed ID: 3265770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the origins of astrocyte response to injury using the dopaminergic neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    O'Callaghan JP; Miller DB; Reinhard JF
    Brain Res; 1990 Jun; 521(1-2):73-80. PubMed ID: 1976416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diethyldithiocarbamate potentiates the neurotoxicity of in vivo 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and of in vitro 1-methyl-4-phenylpyridinium.
    Miller DB; Reinhard JF; Daniels AJ; O'Callaghan JP
    J Neurochem; 1991 Aug; 57(2):541-9. PubMed ID: 1649252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MAP kinase cascade is activated prior to the induction of gliosis in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of dopaminergic neurotoxicity.
    O'Callaghan JP; Martin PM; Mass MJ
    Ann N Y Acad Sci; 1998 May; 844():40-9. PubMed ID: 9668663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astrocyte-Derived Estrogen Regulates Reactive Astrogliosis and is Neuroprotective following Ischemic Brain Injury.
    Wang J; Sareddy GR; Lu Y; Pratap UP; Tang F; Greene KM; Meyre PL; Tekmal RR; Vadlamudi RK; Brann DW
    J Neurosci; 2020 Dec; 40(50):9751-9771. PubMed ID: 33158962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Connexin 30 deficiency attenuates A2 astrocyte responses and induces severe neurodegeneration in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride Parkinson's disease animal model.
    Fujita A; Yamaguchi H; Yamasaki R; Cui Y; Matsuoka Y; Yamada KI; Kira JI
    J Neuroinflammation; 2018 Aug; 15(1):227. PubMed ID: 30103794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulating effect of Hypericum perforatum extract on astrocytes in MPTP induced Parkinson's disease in mice.
    Mohanasundari M; Sabesan M
    Eur Rev Med Pharmacol Sci; 2007; 11(1):17-20. PubMed ID: 17405345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astrocyte responses to dopaminergic denervations by 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as evidenced by glial fibrillary acidic protein immunohistochemistry.
    Strömberg I; Björklund H; Dahl D; Jonsson G; Sundström E; Olson L
    Brain Res Bull; 1986 Aug; 17(2):225-36. PubMed ID: 3094835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early activation of STAT3 regulates reactive astrogliosis induced by diverse forms of neurotoxicity.
    O'Callaghan JP; Kelly KA; VanGilder RL; Sofroniew MV; Miller DB
    PLoS One; 2014; 9(7):e102003. PubMed ID: 25025494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of S-100 protein is related to neuronal damage in MPTP-treated mice.
    Muramatsu Y; Kurosaki R; Watanabe H; Michimata M; Matsubara M; Imai Y; Araki T
    Glia; 2003 May; 42(3):307-13. PubMed ID: 12673835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroglial responses to the dopaminergic neurotoxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse striatum.
    Francis JW; Von Visger J; Markelonis GJ; Oh TH
    Neurotoxicol Teratol; 1995; 17(1):7-12. PubMed ID: 7535890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal and astroglial responses to the serotonin and norepinephrine neurotoxin: 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine.
    Luellen BA; Miller DB; Chisnell AC; Murphy DL; O'Callaghan JP; Andrews AM
    J Pharmacol Exp Ther; 2003 Dec; 307(3):923-31. PubMed ID: 14561848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astrocytic responses to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in cat and mouse brain.
    Schneider JS; Denaro FJ
    J Neuropathol Exp Neurol; 1988 Jul; 47(4):452-8. PubMed ID: 2898510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of connexin-43, GFAP, and FGF-2 is not accompanied by changes in astroglial coupling in MPTP-lesioned, FGF-2-treated parkinsonian mice.
    Rufer M; Wirth SB; Hofer A; Dermietzel R; Pastor A; Kettenmann H; Unsicker K
    J Neurosci Res; 1996 Dec; 46(5):606-17. PubMed ID: 8951672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allopregnanolone effects on astrogliosis induced by hypoxia in organotypic cultures of striatum, hippocampus, and neocortex.
    Kruse MS; Rey M; Barutta J; Coirini H
    Brain Res; 2009 Dec; 1303():1-7. PubMed ID: 19782663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDMA administration during adolescence exacerbates MPTP-induced cognitive impairment and neuroinflammation in the hippocampus and prefrontal cortex.
    Costa G; Simola N; Morelli M
    Psychopharmacology (Berl); 2014 Oct; 231(20):4007-18. PubMed ID: 24687411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.